Company profile: Endpoints News
1.1 - Company Overview
Company description
- Provider of independent biotech, pharmaceutical, and life sciences news, analysis, and insights covering drug development, clinical trials, regulatory issues, company news, and industry trends. Offers in-depth articles, breaking news updates, special reports, newsletters, briefs, interviews, and channel feeds with continuous updates on R&D, manufacturing, and regulatory affairs.
Products and services
- Endpoints News Articles: Editorial-grade articles analyze biotechnology, pharmaceutical, and health news developments, covering drug development, clinical trials, regulatory issues, company news, and industry trends for business and professional readers
- Endpoints News Special Reports: Research-grade special reports spotlight significant trends, key players, and major developments in the biotech and pharmaceutical industries, offering concentrated coverage of pivotal sector shifts
- Endpoints News Newsletters: Subscriber-grade newsletters deliver curated biotech, pharma, and life sciences news and updates directly to subscribers’ inboxes, summarizing timely developments in drug development, clinical trials, regulatory issues, and company news
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Endpoints News
Tastytrade
HQ: United States
Website
- Description: Provider of a self-directed trading platform offering commission-free U.S. stock and ETF trading with real-time data; low-commission options on stocks/ETFs and futures; futures options with diversified exposure and flexible hours; and commission-free cryptocurrency trading (BTC, ETH, BCH, LTC via Zero Hash). Includes tools for strategy analysis, market insights, and support to empower do-it-yourself investors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tastytrade company profile →
Summify
HQ: Canada
Website
- Description: Provider of daily summaries of users’ social news feeds delivered via email, web, or mobile, accessible via Twitter, Facebook, and Google Reader accounts; headquartered in Vancouver, Canada.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Summify company profile →
NationalWorld
HQ: United Kingdom
Website
- Description: Provider of a modern news publishing platform powered by the latest technology, covering politics, environment, health, sports, culture, and lifestyle, and offering digital subscriptions with monthly and annual payment options for access to content.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NationalWorld company profile →
Outside.in
HQ: United States
Website
- Description: Provider of a neighborhood-focused information aggregation platform enabling communities to share and explore local information, making local blogs the focal point of access rather than forums or reviews; aims to do for blogging what Google local search has done for the web.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Outside.in company profile →
Wealth Management
HQ: United States
Website
- Description: Provider of a digital platform delivering industry news, research, insights, tools, and practice management resources to financial advisors and estate planning professionals via websites, e-newsletters, webinars, videos, social media, and mobile platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wealth Management company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Endpoints News
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Endpoints News
2.2 - Growth funds investing in similar companies to Endpoints News
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Endpoints News
4.2 - Public trading comparable groups for Endpoints News
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →